av/lipocine--big.svg

NASDAQ:LPCN

Lipocine Inc.

  • Stock

USD

Last Close

5.74

17/05 20:00

Market Cap

20.68M

Beta: 0.94

Volume Today

48.39K

Avg: 201.21K

PE Ratio

−1.28

PFCF: −1.78

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
0.50
-
average payables
519.34K
-
666.65K
28.37%
406.67K
39.00%
376.49K
7.42%
421.99K
12.09%
634.67K
50.40%
926.76K
46.02%
1.39M
49.96%
1.44M
3.85%
944.87K
34.53%
998.18K
5.64%
average receivables
72.27K
-
91.74K
26.94%
1.69M
1,743.23%
1.69M
0.01%
27.52K
98.37%
8.46K
69.27%
123.82K
1,364.22%
453.55K
266.30%
329.93K
27.26%
book value per share
103.49
-
35.10
66.08%
21.67
38.27%
24.22
11.80%
16.09
33.57%
7.51
53.32%
4.13
45.01%
4.68
13.40%
8.91
90.27%
0.40
95.48%
3.87
859.52%
capex per share
-0.00
-
-0.08
2,750.70%
-0.01
81.35%
-0.06
275.13%
-0.00
-
-0.00
1.92%
-0.00
65.15%
capex to depreciation
-0.06
-
-4.08
7,258.82%
-1.07
73.67%
-1.87
73.84%
-19.98
-
-14.16
29.13%
-0.46
96.76%
capex to operating cash flow
0.00
-
0.00
2,353.14%
0.00
45.77%
0.00
74.65%
0.00
-
0.01
549.79%
0.00
92.48%
capex to revenue
-0.00
-
-0.27
56,813.30%
0.00
101.73%
cash per share
104.51
-
36.84
64.75%
22.90
37.83%
24.99
9.11%
18.20
27.17%
12.14
33.29%
9.24
23.90%
6.00
35.03%
8.73
45.32%
0.37
95.79%
4.18
1,037.08%
days of inventory on hand
days payables outstanding
73.17
-
7.22
90.13%
14.71
103.71%
11.11
24.45%
19.84
78.49%
37.90
91.06%
57.78
52.45%
59.80
3.50%
61.39
2.66%
25.61
58.29%
days sales outstanding
32.84
-
36.55
11.29%
5.59
-
481.69
8,515.15%
debt to assets
0.49
-
0.36
26.10%
0.22
39.36%
0.04
80.03%
debt to equity
1.09
-
1.14
4.52%
0.36
67.95%
0.05
86.08%
dividend yield
earnings yield
-0.17
-
-0.30
74.02%
-0.04
85.91%
-0.28
560.50%
-0.30
7.73%
-0.42
38.09%
-1.30
210.52%
-0.28
78.78%
-0.01
97.34%
-0.02
144.01%
-1.11
6,090.88%
enterprise value
15.48M
-
39.48M
155.04%
405.93M
928.06%
61.63M
84.82%
65.77M
6.72%
29.94M
54.48%
7.39M
75.31%
62.11M
740.27%
85.53M
37.71%
595.71M
596.51%
9.93M
98.33%
enterprise value over ebitda
-2.27
-
-1.93
15.18%
-22.11
1,047.11%
-3.48
84.25%
-3.10
10.87%
-2.65
14.69%
-0.56
78.73%
-3.47
515.36%
26.62
867.86%
-51.59
293.82%
-0.61
98.82%
ev to operating cash flow
-1.80
-
-2.28
26.58%
-26.43
1,058.47%
-3.37
87.25%
-3.94
16.81%
-2.48
37.05%
-0.63
74.44%
-4.06
540.58%
-19.39
377.71%
-49.77
156.71%
-0.63
98.73%
ev to sales
69.95
-
44.80
35.95%
5.30
-
1.19K
22,384.41%
-3.48
100.29%
free cash flow per share
-19.83
-
-23.12
16.59%
-7.94
65.66%
-17.08
115.09%
-14.16
17.09%
-9.62
32.08%
-7.66
20.32%
-4.67
39.03%
-0.86
81.50%
-0.14
84.17%
-2.98
2,075.08%
free cash flow yield
-0.14
-
-0.26
82.87%
-0.04
86.03%
-0.27
655.75%
-0.24
11.30%
-0.44
79.71%
-1.17
168.84%
-0.20
82.73%
-0.05
74.62%
-0.02
60.59%
-1.07
5,177.88%
graham net net
101.54
-
34.67
65.86%
21.21
38.82%
23.78
12.13%
14.95
37.15%
3.07
79.43%
0.47
84.82%
2.95
531.72%
7.41
151.35%
0.35
95.25%
3.68
946.75%
graham number
238.61
-
146.38
38.65%
67.68
53.76%
98.12
44.97%
80.25
18.21%
39.61
50.65%
28.18
28.86%
25.97
7.83%
4.99
80.80%
1.05
78.95%
16.43
1,464.63%
income quality
0.81
-
0.85
4.73%
0.84
0.71%
0.96
14.26%
0.80
17.40%
1.04
30.14%
0.90
13.42%
0.73
18.61%
6.95
852.61%
1.11
84.00%
0.96
13.87%
intangibles to total assets
0
-
0
-0.62
Infinity%
0
100%
0
0
0
0
0
0
0
interest coverage
-46.55
-
15.47
133.24%
-447.24
2,990.50%
interest debt per share
8.17
-
4.69
42.53%
1.82
61.14%
0.49
73.06%
0.00
99.94%
inventory turnover
invested capital
1.09
-
1.14
4.52%
0.36
67.95%
0.05
86.08%
market cap
60.75M
-
67.15M
10.54%
425.94M
534.30%
67.19M
84.23%
68.98M
2.66%
27.76M
59.76%
9.97M
64.07%
75.74M
659.46%
86.17M
13.77%
598.86M
594.99%
14.70M
97.54%
net current asset value
44.75M
-
26.26M
41.31%
41.49M
57.97%
25.88M
37.61%
18.87M
27.08%
9.39M
50.24%
6.26M
33.33%
15.32M
144.68%
39.47M
157.65%
32.23M
18.34%
20.23M
37.23%
net debt to ebitda
6.64
-
1.35
79.67%
1.09
19.31%
0.31
71.17%
0.15
51.78%
-0.19
227.37%
0.20
201.91%
0.76
286.68%
-0.20
126.18%
0.27
236.96%
0.29
7.01%
net income per share
-24.45
-
-27.13
10.95%
-9.40
65.36%
-17.66
87.98%
-17.79
0.71%
-9.28
47.82%
-8.54
7.97%
-6.40
25.09%
-0.12
98.06%
-0.12
1.96%
-3.10
2,451.34%
operating cash flow per share
-19.83
-
-23.04
16.21%
-7.92
65.61%
-17.02
114.79%
-14.16
16.81%
-9.62
32.08%
-7.66
20.32%
-4.67
39.03%
-0.86
81.53%
-0.14
84.31%
-2.97
2,097.55%
payables turnover
4.99
-
50.54
913.23%
24.81
50.91%
32.84
32.37%
18.40
43.97%
9.63
47.66%
6.32
34.41%
6.10
3.38%
5.95
2.59%
14.25
139.72%
receivables turnover
11.11
-
9.99
10.15%
65.28
-
0.76
98.84%
research and ddevelopement to revenue
15.10
-
45.26
199.70%
474.92
-
17.11
96.40%
-3.57
120.86%
return on tangible assets
-0.23
-
-0.73
216.86%
-0.25
66.00%
-0.69
180.39%
-0.83
19.41%
-0.56
32.51%
-0.66
18.33%
-0.83
24.97%
-0.01
98.54%
-0.29
2,270.72%
-0.71
148.08%
revenue per share
0.34
-
0.11
68.20%
3.16
-
0.01
99.82%
-0.54
9,670.83%
roe
-0.24
-
-0.77
227.12%
-0.43
43.89%
-0.73
68.14%
-1.11
51.61%
-1.24
11.80%
-2.07
67.37%
-1.37
33.94%
-0.01
98.98%
-0.30
2,068.69%
-0.80
165.90%
roic
-0.24
-
-0.78
227.68%
-0.44
43.65%
-0.74
68.45%
-1.12
51.58%
-0.58
48.55%
-0.96
66.95%
-0.86
10.46%
0.07
107.64%
-0.34
617.57%
-0.80
136.03%
sales general and administrative to revenue
12.36
-
33.92
174.53%
0.33
-
8.12
2,360.59%
-1.72
121.18%
shareholders equity per share
103.49
-
35.10
66.08%
21.67
38.27%
24.22
11.80%
16.09
33.57%
7.51
53.32%
4.13
45.01%
4.68
13.40%
8.91
90.27%
0.40
95.48%
3.87
859.52%
stock based compensation to revenue
3.41
-
6.28
84.35%
0.04
-
1.27
3,300.25%
-0.23
118.04%
tangible asset value
44.82M
-
26.36M
41.19%
70.19M
166.27%
26.02M
62.93%
18.98M
27.05%
9.43M
50.30%
6.29M
33.35%
15.34M
144.00%
45.57M
197.03%
35.63M
21.80%
20.37M
42.84%
tangible book value per share
103.49
-
35.10
66.08%
21.67
38.27%
24.22
11.80%
16.09
33.57%
7.51
53.32%
4.13
45.01%
4.68
13.40%
8.91
90.27%
0.40
95.48%
3.87
859.52%
working capital
44.75M
-
26.26M
41.31%
41.49M
57.97%
25.88M
37.61%
18.87M
27.08%
16.32M
13.55%
14.67M
10.12%
18.75M
27.81%
40.76M
117.46%
32.46M
20.38%
20.23M
37.67%

All numbers in USD (except ratios and percentages)